JP2025516569A5 - - Google Patents

Info

Publication number
JP2025516569A5
JP2025516569A5 JP2024566281A JP2024566281A JP2025516569A5 JP 2025516569 A5 JP2025516569 A5 JP 2025516569A5 JP 2024566281 A JP2024566281 A JP 2024566281A JP 2024566281 A JP2024566281 A JP 2024566281A JP 2025516569 A5 JP2025516569 A5 JP 2025516569A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566281A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516569A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066811 external-priority patent/WO2023220620A2/en
Publication of JP2025516569A publication Critical patent/JP2025516569A/ja
Publication of JP2025516569A5 publication Critical patent/JP2025516569A5/ja
Pending legal-status Critical Current

Links

JP2024566281A 2022-05-13 2023-05-10 5t4抗体薬物複合体及びその使用 Pending JP2025516569A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263341957P 2022-05-13 2022-05-13
US63/341,957 2022-05-13
PCT/US2023/066811 WO2023220620A2 (en) 2022-05-13 2023-05-10 5t4 antibody-drug conjugates and uses thereof

Publications (2)

Publication Number Publication Date
JP2025516569A JP2025516569A (ja) 2025-05-30
JP2025516569A5 true JP2025516569A5 (cg-RX-API-DMAC10.html) 2026-05-18

Family

ID=88731090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566281A Pending JP2025516569A (ja) 2022-05-13 2023-05-10 5t4抗体薬物複合体及びその使用

Country Status (16)

Country Link
US (1) US20250295803A1 (cg-RX-API-DMAC10.html)
EP (1) EP4522157A2 (cg-RX-API-DMAC10.html)
JP (1) JP2025516569A (cg-RX-API-DMAC10.html)
KR (1) KR20250024875A (cg-RX-API-DMAC10.html)
CN (2) CN119522097A (cg-RX-API-DMAC10.html)
AU (1) AU2023268538A1 (cg-RX-API-DMAC10.html)
CA (1) CA3252237A1 (cg-RX-API-DMAC10.html)
CL (1) CL2024003441A1 (cg-RX-API-DMAC10.html)
CO (1) CO2024015381A2 (cg-RX-API-DMAC10.html)
CR (1) CR20240491A (cg-RX-API-DMAC10.html)
DO (1) DOP2024000233A (cg-RX-API-DMAC10.html)
IL (1) IL316790A (cg-RX-API-DMAC10.html)
MX (1) MX2024013869A (cg-RX-API-DMAC10.html)
PE (1) PE20251184A1 (cg-RX-API-DMAC10.html)
TW (1) TW202408585A (cg-RX-API-DMAC10.html)
WO (1) WO2023220620A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250060248A (ko) * 2022-09-07 2025-05-07 엑셀리시스, 인코포레이티드 조직 인자 항체-약물 접합체 및 이의 용도
KR20260114567A (ko) * 2023-11-15 2026-07-22 엑셀리시스, 인코포레이티드 5t4 항체 약물 접합체 및 이의 사용 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020006010A (es) * 2017-12-11 2020-10-16 Triphase Res And Development Iii Corp Conjugados de anticuerpo anti-cd22-maitansina, combinaciones y metodos de uso de los mismos.

Similar Documents

Publication Publication Date Title
JP7381478B2 (ja) 単一分子量ポリサルコシンを含むリガンド-薬物-複合体
JP2022518743A5 (cg-RX-API-DMAC10.html)
ES2885686T3 (es) Conjugados anticuerpo-fármaco hidrófilos
JP2024512986A5 (cg-RX-API-DMAC10.html)
JP2025131777A5 (cg-RX-API-DMAC10.html)
JP2016518332A5 (cg-RX-API-DMAC10.html)
JP2023529415A (ja) 高安定性の親水性結合ユニットを有するカンプトテシン類薬物及びその複合体
JP2022548908A (ja) カンプトテシン誘導体及びその複合体
JP2024512986A (ja) 改良された物理化学的特性および薬理学的特性を有する酵素トリガー自己反応性リンカー
JP2018501781A5 (cg-RX-API-DMAC10.html)
JP2022530524A5 (cg-RX-API-DMAC10.html)
JP6704900B2 (ja) ポリオキサゾリン抗体薬物複合体
WO2024227439A1 (zh) 具有靶向作用的偶联物及其制备方法和用途
JP6321687B2 (ja) アマトキシン誘導体
JP2016512832A5 (cg-RX-API-DMAC10.html)
JP2025509286A5 (cg-RX-API-DMAC10.html)
JP2019501214A5 (cg-RX-API-DMAC10.html)
JP2024529466A5 (cg-RX-API-DMAC10.html)
WO2024235136A9 (zh) 杂环类化合物及其制备方法和用途
WO2024235134A1 (zh) 具有靶向作用的偶联物及其制备方法和用途
CN120957758A (zh) 大环化合物及其制备方法和用途
WO2024235130A1 (zh) 多环化合物及其制备方法和用途
WO2024235133A9 (zh) 多环类药物偶联物及其制备方法和用途
JP2025516569A (ja) 5t4抗体薬物複合体及びその使用
WO2024235123A1 (zh) 具有抗肿瘤作用的化合物及其制备方法和用途